Hologic to Present at Needham & Company Growth Conference
PRNewswire-FirstCall
BEDFORD, Mass.

BEDFORD, Mass., Jan. 2, 2008 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Tenth Annual Needham & Company Growth Conference being held January 8-11, 2008 at the Palace Hotel in New York, NY.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, January 8, 2008 at 3:30 p.m. Eastern Time on the investor section of the Company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a diversified diagnostic and medical product and device company dedicated to serving the healthcare needs of women. Historically, we have developed, manufactured and marketed products focused on mammography, breast care and osteoporosis assessment. In October 2007, we completed our business combination with Cytyc Corporation, a company that develops, manufactures and markets a complementary product line covering a range of cancer and women's health applications, including cervical cancer screening, treatment of excessive menstrual bleeding, and radiation treatment of early- stage breast cancer. As a result of our business combination with Cytyc, we have become one of the largest companies in the world focused on creating innovative and clinically effective advanced technologies in women's health. For more information visit www.hologic.com.


Contact:
Glenn Muir
Executive Vice President and CFO
Hologic, Inc.
Tel: 781.999.7300


Frances Crecco
Director, Investor Relations
Hologic, Inc.
fcrecco@hologic.com
Tel: (781) 999-7377

 

SOURCE: Hologic, Inc.